1019-206 Reduced adverse event rates after transcatheter closure of patent foramen ovale when using the amplatzer-PFO™ compared to the CardioSeal™ device

Authors :: Robert R. Pearson
Peter J. Casterella
Sherman G. Sorensen
Joseph B. Muhlestein
Jeffrey L. Anderson
Benjamin D. Horne
Donald L Lappe
Laurie Raleigh
Source :: Journal of the American College of Cardiology. (5):A377
Publisher :: Published by Elsevier Inc.

Subjects :: medicine.medical_specialty
business.industry
Closure (topology)
Patent foramen ovale
cardiovascular system
Medicine
cardiovascular diseases
business
Adverse effect
medicine.disease
Cardiology and Cardiovascular Medicine
Surgery

Full Text Access

Tools